Filing Details
- Accession Number:
- 0001415889-22-012652
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-19 07:09:44
- Reporting Period:
- 2022-12-16
- Accepted Time:
- 2022-12-19 07:09:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1719406 | Nrx Pharmaceuticals Inc. | NRXP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1284934 | Seth Voorhees Van | C/O Nrx Pharmaceuticals Inc 1201 N. Market Street, Suite 111 Wilmington DE 19801 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2022-12-16 | 30,000 | $1.10 | 46,337 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.09 to $1.11. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer or any security holder of the Issuer, upon request, full information regarding the number of shares of the Common Stock and prices at which the transaction was effected.
Billionaire Hedge Funds
